A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis-Reference-Cited by-同舟云学术

A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis

Published:2015-05 Issue:9 Volume:191 Page:1058-1065
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Boeree Martin J.,Diacon Andreas H.,Dawson Rodney,Narunsky Kim,du Bois Jeannine,Venter Amour,Phillips Patrick P. J.,Gillespie Stephen H.,McHugh Timothy D.,Hoelscher Michael,Heinrich Norbert,Rehal Sunita,van Soolingen Dick,van Ingen Jakko,Magis-Escurra Cecile,Burger David,Plemper van Balen Georgette,Aarnoutse Rob E.

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference32 articles.

1. Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?

2. Dose-Finding Studies in Phase I and Estimation of Maximally Tolerated Dose

3. Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin

4. Pharmacokinetics-Pharmacodynamics of Rifampin in an Aerosol Infection Model of Tuberculosis

Cited by 270 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis;Trends in Parasitology;2024-09

2. Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles;The Lancet Microbe;2024-09

3. ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis;Indian Journal of Critical Care Medicine;2024-08-10

4. Pharmacokinetics of standard versus high-dose rifampin for tuberculosis preventive treatment: A sub-study of the 2R2 randomized controlled trial;International Journal of Antimicrobial Agents;2024-07

5. Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial;The Lancet Global Health;2024-06